Skip to main content
SkinCited

Nicotinamide
Nicotinamide

specialty

别名: Nicotinamide (high-dose oral), Vitamin B3 (oral oncology dose)

<\/script>\n
`; }, get iframeSnippet() { const domain = 'skincited.com'; const params = 'ingredient\u003Dnicotinamide'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

About

Nicotinamide at chemoprevention doses replenishes cellular NAD+ depleted by UV-induced PARP activation, enhancing cellular energy for DNA repair. The landmark ONTRAC trial (386 patients, NEJM 2015) found nicotinamide 500 mg twice daily reduced new nonmelanoma skin cancers by 23% and actinic keratoses by 11% in high-risk individuals.

How It Works

Amide form of vitamin B3 (distinct from niacinamide in dosing context); replenishes cellular NAD+ depleted by UV-induced PARP activation; enhances cellular energy for DNA repair; supports immune surveillance of skin cancer precursors; strengthens skin barrier ceramide synthesis.

Evidence For Conditions

健康状况 等级 研究数量 受试者
UV Protection (Internal Photoprotection) A 5 686 查看 →

Side Effects

  • Generally well-tolerated (no flushing)
  • Mild gastrointestinal discomfort at high doses
  • Rare hepatotoxicity at very high doses

Drug & Supplement Interactions

  • Anticonvulsants (carbamazepine — may increase levels)
  • Isoniazid (competes for NAD+ pathways)
  • Hepatotoxic drugs (potential additive liver effect at high doses)

请务必告知您的医疗保健提供者您正在服用的所有补充剂。

Related Ingredients

FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。